Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia

Leukemia Research

Volumn 30, Issue 9, 2006, Pages 1159-1165

  Ruan, Guo Rui ^a   Qin, Ya Zhen ^a   Chen, Shan Shan ^a   Li, Jin Lan ^a   Ma, Xi ^b   Chang, Yan ^a   Wang, Ya Zhe ^a   Fu, Jia Yu ^a   Liu, Yan Rong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia (AML); Apoptosis; Chronic myeloid leukemia (CML); Imatinib mesylate; Programmed cell death 5 (PDCD5); Real time quantitative reverse transcription polymerase chain reaction (RQ RT PCR)

Indexed keywords

BCR ABL PROTEIN; IMATINIB;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL STRAIN K 562; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; PRIORITY JOURNAL; PROGRAMMED CELL DEATH 5 GENE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; APOPTOSIS REGULATORY PROTEINS; BONE MARROW CELLS; FEMALE; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; K562 CELLS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE; NEOPLASM PROTEINS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES;

EID: 33745813515     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.12.028     Document Type: Article

References (17)

1. Schimmer A.D., Hedley D.W., Penn L.Z., and Minden M.D. Receptor- and mitochondrial-mediated apoptosis in acute leukemia: translational view. Blood 98 13 (2001) 3541-3553
2. Schuler D., and Szende B. Apoptosis in acute leukemia. Leuk Res 28 7 (2004) 661-666
3. Liu H., Wang Y., Zhang Y., Song Q., Di C., Chen G., et al. TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. Biochem Biophys Res Commun 254 1 (1999) 203-210
4. Chen Y., Sun R., Han W., Zhang Y., Song Q., Di C., et al. Nuclear translocation of PDCD5 (TFAR19): an early signal for apoptosis?. FEBS Lett 509 2 (2001) 191-196
5. Ruan G.R., Chen S.S., Chang Y., Fu J.Y., Wan H., Qin Y.Z., et al. Abnormality expression of a novel apoptosis-promoting molecule TFAR19 (PDCD5) in the bone marrow cells from adult chronic myeloid leukemia. J Peking Univ (Health Sci) 34 6 (2002) 676-679
6. Beillard E., Pallisgaard N., van der Velden V.H., Bi W., Dee R., van der Schoot E., et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-A Europe against cancer program. Leukemia 17 12 (2003) 2474-2486
7. Bedi A., Barber J.P., Bedi G.C., el-Deiry W.S., Sidransky D., Vala M.S., et al. BCR-ABL mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood 86 3 (1995) 1148-1158
8. Ravandi F., Kantarjian H.M., Talpaz M., O'Brien S., Faderl S., Giles F.J., et al. Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance. Cancer 91 11 (2001) 1964-1972
9. Handa H., Hegde U.P., Kotelnikov V.M., Mundle S.D., Dong L.M., Burke P., et al. BCL-2 and C-MYC expression, cell cycle kinetics and apoptosis during the progression of chronic myelogenous leukemia from diagnosis to blastic phase. Leuk Res 21 6 (1997) 479-489
10. Xu M., Cheng N., Gui L., Lai M., Wang Y., Xia D., et al. The 5′-upstream region of human programmed cell death 5 gene contains a highly active TATA-less promoter that is up-regulated by etoposide. Gene 329 (2004) 39-49
11. Wang Y., Li X., Wang L., Ding P., Zhang Y., Han W., et al. An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J Cell Sci 117 Pt 8 (2004) 1525-1532
12. Xu X.R., Huang J., Xu Z.G., et al. Insight into heptocellular carcinogenesis at transcriptome level by comparing gene expression profiles of heptocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 98 26 (2001) 15089-15094
13. Hedenfalk I., Duggan D., Chen Y., Radmacher M., Bittner M., Simon R., et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 344 8 (2001) 539-548
14. Zucchi I., Mento E., Kuznetsov V.A., Scotti M., Valsecchi V., Simionati B., et al. Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis. Proc Natl Acad Sci USA 101 52 (2004) 18147-18152
15. Calabretta B., and Perrotti D. The biology of CML blast crisis. Blood 103 11 (2004) 4010-4022
16. Moriai R., Asanuma K., Kobayashi D., Yajima T., Yagihashi A., Yamada M., et al. Quantitative analysis of the anti-apoptotic gene survivin expression in malignant haematopoietic cells. Anticancer Res 21 1B (2001) 595-600
17. Gesbert F., and Griffin J. Bcr/Abl activates transcription of Bcl-X gene through STAT 5. Blood 96 6 (2000) 2269-2276